FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Keeps Hold Opinion On Shares Of Public Storage

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our target by $4 to $322 on a forward P/FFO of 19.2x our 2026 FFO estimate, a premium to self-storage peers at 16.7x and to PSA's three-year forward average P/FFO of 17.4x. We decrease our 2025 FFO view by $0.26 to $16.73 and decrease 2027 by $0.09 to $17.93. Q1's most positive news was a material reduction in customer churn that led to lower move-out activity, improving occupancy by 40 bps Y/Y. If this continues throughout FY 2026 we would have to increase our FFO outlook. However, weakness remains in the Sun Belt markets, with Atlanta, Phoenix, and parts of Florida facing headwinds from negative same-property revenue growth Y/Y. Los Angeles also remains a drag, with the state of emergency negatively impacting pricing and creating an 80 bps drag on same-store revenue growth this year. We expect PSA's top-line performance to weaken in Q2-Q3 this year with revenue headwinds before the outlook improves in Q4 heading into 2027.

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU